NEW YORK (GenomeWeb News) – Horizon Discovery said today that it has launched a subsidiary called Horizon Dx to support the development, approval, and sale of companion diagnostics, initially in the area of cancer.

Horizon Dx, or HDx, will use Horizon Discovery's panel of more than 175 X-MAN human isogenic cell models that recapitulate drug sensitivity and resistance mechanisms in cancer patients. These cell models use a proprietary gene-engineering technology called GENESIS that enables rapid and precise alteration of any endogenous gene loci in human cells.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.